Skip to main content

Drug Recall Tracker

Check for active and recent drug recalls

Recall Severity Classes

Class I

Dangerous or defective products that could cause serious health problems or death.

Class II

Products that might cause a temporary health problem, or pose a slight threat of a serious nature.

Class III

Products that are unlikely to cause any adverse health reaction, but that violate FDA labeling or manufacturing laws.

Losartan Potassium

Class IIOngoing

Multiple manufacturers

Mar 2024

Reason

NDMA (N-Nitrosodimethylamine) contamination — a probable human carcinogen detected above acceptable daily intake limits during manufacturing.

Affected Products

Losartan 25mg, 50mg, and 100mg tablets (multiple lot numbers)

What to Do

Check your medication lot number. If affected, contact your pharmacy for a replacement from a different manufacturer.

Metformin Hydrochloride

Class IIMostly Resolved

Multiple manufacturers

Jun 2020

Reason

NDMA contamination found in extended-release (ER) formulations at levels exceeding acceptable daily intake. Immediate-release versions were not affected.

Affected Products

Metformin ER 500mg, 750mg, 1000mg tablets (specific lot numbers)

What to Do

Most affected lots have been removed from the market. Continue taking your medication unless your pharmacist advises otherwise — the risk of stopping metformin is usually greater.

Ranitidine (Zantac)

Class IMarket Withdrawal

All manufacturers

Apr 2020

Reason

NDMA found to increase over time and when stored at higher temperatures. The FDA requested all ranitidine products be withdrawn from the US and Canadian markets.

Affected Products

ALL ranitidine products (brand and generic, OTC and prescription)

What to Do

Switch to an alternative: famotidine (Pepcid), omeprazole (Prilosec), or esomeprazole (Nexium). Ranitidine is no longer available.

Valsartan

Class IResolved

Zhejiang Huahai, Torrent, Mylan, others

Jul 2018

Reason

NDMA and NDEA contamination traced to changes in manufacturing process at Chinese API (active pharmaceutical ingredient) supplier.

Affected Products

Valsartan tablets and valsartan/HCTZ combination products from multiple manufacturers

What to Do

Affected lots have been fully recalled and removed. Current valsartan products on the market are safe.

Acetaminophen (Infants' Tylenol)

Class IIIResolved

Johnson & Johnson

Nov 2023

Reason

Potential metal particulate contamination detected during quality testing. Particles could pose a choking risk or minor GI irritation.

Affected Products

Infants' Tylenol Oral Suspension, Cherry flavor, select lot numbers

What to Do

Affected lots were recalled from retail shelves. Current products are unaffected.

Amlodipine Besylate

Class IResolved

Apotex Corp

Aug 2023

Reason

Tablet mix-up: some bottles labeled as amlodipine 5mg may contain losartan 50mg tablets, posing a risk of wrong medication administration.

Affected Products

Amlodipine Besylate Tablets 5mg, 500-count bottles, specific lot numbers

What to Do

Verify your tablets match the description on the bottle. Contact your pharmacy if they look different from usual.

Official Recall Databases

For the most up-to-date recall information, check these official government databases: